MAM
VinFast India hires Bhartendu Singh as chief marketing officer
GURUGRAM: VinFast India has roped in Bhartendu Singh as chief marketing officer, adding a seasoned automotive marketer to its leadership ranks as the Vietnamese EV maker revs up operations in the country. Singh moves from Hyundai Motor India, where he was general manager for marketing and domain head.
Singh announced the shift on LinkedIn, calling his new role at VinFast India an exciting next chapter. Based in Gurugram, he brings more than two decades of experience across automotive and consumer durables, with stints at Hyundai, Johnson Controls, Hitachi Air Conditioning, Honda Motorcycle & Scooter India, AIMA and Wings Media. His career has spanned brand building, product communication and market development across multiple consumer categories.
With VinFast seeking to crack one of the world’s most competitive EV markets, Singh’s blend of sector depth and marketing muscle signals a sharper push for visibility and scale. And with a veteran marketer now in the cockpit, the company looks set to hit the accelerator.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
